Global Neuropathic Pain Market is growing with factors such as growing prevalence of chronic pain and neuropathic condition and increasing cases of diabetic neuropathy also acts as a major factor for the growth of the market. Advancement in new neuromodulation technology and penetration of new market player have also given a boom to the global neuropathic pain market.
High risk of neuropathic pain with ageing has propelled the demand of the market. However, high cost of these medical devices and unfavorable government policies has decreased the demand of the market.
Neuropathic Pain Market Scenario
According to Data Bridge Market Research, the market for neuropathic pain in North America has the highest market share followed by Europe and Asia-Pacific. Market leader is Medtronic which accounts an estimated market share of approximately 24.10% in the global neuropathic pain market. The company has gained outstanding sale by providing advanced neuropathic pain devices. For instances,
- In January 2020, Medtronic announced that it has achieved second rank in the FORTUNE’s 2020 World’s Most Admired Companies List. This recognition achieved by the company has enhanced its credibility in the market leading to increased demand for its product in the several markets including neuropathic pain market among others.
Trends Impacting the Market
Now the question is which other regions Medtronic, Boston Scientific Corporation and Abbott are targeting? Data Bridge Market Research has forecasted a large growth in North America neuropathic pain market and the market leaders targeting U.S. and Canada to be their next pocket revenue for 2021.
The neuropathic pain market is becoming more competitive with companies such as Medtronic, Boston Scientific Corporation and Abbott. These are the top dominating companies in neuropathic pain market and have launched advanced neuropathic pain devices in the market. The data bridge market research new reports highlight the major growth factors and opportunities in the global neuropathic pain market.
For more analysis on the global neuropathic pain market request for a briefing with our analysts https://www.databridgemarketresearch.com/reports/global-neuropathic-pain-market
Neuropathic Pain Market Developments
- In January 2020, Medtronic announced that it has been awarded as one of three recipients of the 2020 Catalyst Award. The company has achieved this award in recognition for its initiatives for the women at workplace. This has promoted credibility of the company in the existing market.
- In December 2021, Boston Scientific Corporation launched WaveWriter Alpha Spinal Cord Stimulator Systems. This product launched is indicated for treatment of chronic pain and can be used in the neuropathic pain. This launch boosted the company’s product portfolio and helped it gain the market share in the forecasted period.
- In January 2021, Abbott had completed the acquisition of St. Jude Medical, Inc., the company who has been considered as a leader in medical devices. This acquisition helped the company to expand their market in terms of medical devices in upcoming future. This acquisition helped the company to boost up their product portfolio in the terms of medical devices, branded, and generic pharmaceuticals. It also has strengthen their global medical devices market and expand their business in upcoming future.
Scope of the Global Neuropathic Pain market
Neuropathic pain market is segmented on the basis of countries into the U.S., Canada, Mexico, Germany, U.K., France, Italy, Spain, Netherlands, Russia, Switzerland, Belgium, Turkey, Austria, Norway, Hungary, Lithuania, Ireland, Poland, Rest of Europe, Japan, China, Australia, India, South Korea, Singapore, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Rest of Asia-Pacific, Brazil, Argentina, Peru, Rest of South America, Saudi Arabia, South Africa, UAE, Israel, Kuwait, Egypt and Rest of Middle East and Africa.
- All country based analysis of the global neuropathic pain market is further analysed based on maximum granularity into further segmentation. On the basis of type, the neuropathic pain market is segmented into spinal cord stimulation (SCS) devices, external peripheral nerve stimulation and transcutaneous electrical nerve stimulation (TENS) devices. On the basis of procedure, the neuropathic pain market is segmented into invasive and non-invasive. On the basis of technology, the neuropathic pain market is segmented into transcutaneous electrical nerve stimulation, transcranial magnetic stimulation and respiratory electrical stimulation. On the basis of modality, the neuropathic pain market is segmented into stationary and portable. On the basis of mode of purchase, the neuropathic pain market is segmented into over-the-counter devices and prescription-based devices. On the basis of pain type, the neuropathic pain market is segmented into peripheral neuropathy, entrapment neuropathy, phantom limb neuropathy, trigeminal neuralgia, post herpetic neuralgia, (PHN) post traumatic neuropathy, foot pain and coccydynia. On the basis of indication, the neuropathic pain market is segmented into spinal stenosis, chemotherapy-induced peripheral neuropathy, diabetic neuropathy and others. On the basis of end user, the neuropathic pain market is segmented into hospitals, clinics, home healthcare, ambulatory surgical centers and others. On the basis of distribution channel, the neuropathic pain market is segmented into direct tender, third party distributor and others
To know more about the study https://www.databridgemarketresearch.com/reports/global-neuropathic-pain-market
Key Pointers Covered in Global Neuropathic Pain Market Industry Trends and Forecast to 2028
- Market Size
- Top to Bottom Market Analysis
- Recent Developments for Market Competitors
- Recent Market Value for Different Countries
- Market value and over view of Neuropathic pain market
- Company profiling of top eight players of Neuropathic pain market
Key Market Competitors Covered in the Report
- NERVO CORP.
- SPR Therapeutics
- Stimwave LLC
- AVNS
- Cirtec
- Integer Holdings Corporation
- B. Braun Melsungen AG
- Medtronic
- Abbott
- Boston Scientific Corporation
- Omron Healthcare Inc.
- electroCore, Inc.
- Polar Medical
- SunMed
- NeuroMetrix, Inc.
Above are the key players covered in the report, to know about more and exhaustive list of neuropathic pain companies’, contact us https://www.databridgemarketresearch.com/reports/europe-nerve-repair-and-regeneration-market
Research Methodology: Global Neuropathic Pain Market
Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and forecasted using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your enquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include vendor positioning grid, market timeline analysis, market overview and guide, company positioning grid, company market share analysis, standards of measurement, top to bottom analysis and vendor share analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Primary Respondents
- Demand Side: Manufacturer, Oncologists, Healthcare Industry, Scientists, Research Laboratories
- Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, and Regulatory Affairs Managers among others.
Related Reports
- Europe Nerve Regeneration and Repair Market - Industry Trends and Forecast to 2027
- Global Peripheral Neuropathy Market - Industry Trends and Forecast to 2027
Browse in Healthcare Category Related Reports@ https://www.databridgemarketresearch.com/report-category/healthcare/
